The company's president suggested that the program could help employer plans expand access to fertility treatments.

In a notable development for investors, Barclays analyst Andrew Mok CFA has maintained a Buy rating on Cigna (CI), setting a price target of $383.00. This announcement comes as Cigna's shares closed ...

As it turns out, Cigna subscribers are the most satisfied expecting moms. More than four out of five moms (84%) say they were ...

HealthEquity HQY recently unveiled two major consumer-focused initiatives — an integrated telehealth platform for GLP-1 ...

After Nov. 30, patients who have an Aetna plan and use Intercoastal Medical Group will have to change doctors or get new ...